MedTrace Logo

Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC)

NCT01732432 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2015-04-01

No results posted yet for this study

Summary

The purpose of this study is to determine whether a relationship exists between a previously established diagnosis of endometriosis and the consecutive risk of developing a clear cell or endometrioid ovarian carcinoma. All histopathological records since 1980 with these diagnoses (endometriosis, clear cell and endometrioid ovarian carcinoma) will be reviewed. Cancer registry data will be assessed to investigate differences in survival of women with endometriosis-associated ovarian carcinomas and those ovarian carcinoma patients without previous diagnosis of endometriosis.

Conditions

  • Endometrioid Carcinoma
  • Clear Cell Carcinoma
  • Endometriosis

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Ellen Obermann, MD, Dr. · University Hospital Basel, University of Basel

  • Ellen C Obermann, MD · Institute of Pathology, University Hospital Basel, University of Basel

Eligibility

Min Age
30 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-08-31
Completion
2013-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01732432 on ClinicalTrials.gov